Cytosporin Derivatives from Arctic-Derived Fungus Eutypella sp. D-1 via the OSMAC Approach

A chemical investigation of the Arctic-derived fungus Eutypella sp. D-1 based on the OSMAC (one strain many compounds) approach resulted in the isolation of five cytosporin polyketides (compounds 1 – 3 and 11 – 12 ) from rice medium and eight cytosporins (compounds 2 and 4 – 11 ) from solid defined...

Full description

Bibliographic Details
Published in:Marine Drugs
Main Authors: Hao-Bing Yu, Zhe Ning, Bo Hu, Yu-Ping Zhu, Xiao-Ling Lu, Ying He, Bing-Hua Jiao, Xiao-Yu Liu
Format: Article in Journal/Newspaper
Language:English
Published: MDPI AG 2023
Subjects:
Online Access:https://doi.org/10.3390/md21070382
https://doaj.org/article/91f3884534b04a2d9e2db2df8de5d4aa
id ftdoajarticles:oai:doaj.org/article:91f3884534b04a2d9e2db2df8de5d4aa
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:91f3884534b04a2d9e2db2df8de5d4aa 2023-08-20T04:04:02+02:00 Cytosporin Derivatives from Arctic-Derived Fungus Eutypella sp. D-1 via the OSMAC Approach Hao-Bing Yu Zhe Ning Bo Hu Yu-Ping Zhu Xiao-Ling Lu Ying He Bing-Hua Jiao Xiao-Yu Liu 2023-06-01T00:00:00Z https://doi.org/10.3390/md21070382 https://doaj.org/article/91f3884534b04a2d9e2db2df8de5d4aa EN eng MDPI AG https://www.mdpi.com/1660-3397/21/7/382 https://doaj.org/toc/1660-3397 doi:10.3390/md21070382 1660-3397 https://doaj.org/article/91f3884534b04a2d9e2db2df8de5d4aa Marine Drugs, Vol 21, Iss 382, p 382 (2023) cytosporin arctic fungus Eutypella sp immunosuppressive activity Biology (General) QH301-705.5 article 2023 ftdoajarticles https://doi.org/10.3390/md21070382 2023-07-30T00:35:20Z A chemical investigation of the Arctic-derived fungus Eutypella sp. D-1 based on the OSMAC (one strain many compounds) approach resulted in the isolation of five cytosporin polyketides (compounds 1 – 3 and 11 – 12 ) from rice medium and eight cytosporins (compounds 2 and 4 – 11 ) from solid defined medium. The structures of the seven new compounds, eutypelleudesmane A ( 1 ), cytosporin Y ( 2 ), cytosporin Z ( 3 ), cytosporin Y 1 ( 4 ), cytosporin Y 2 ( 5 ), cytosporin Y 3 ( 6 ), and cytosporin E 1 ( 7 ), were elucidated by analyzing their detailed spectroscopic data. Structurally, cytosporin Y 1 ( 4 ) may be a key intermediate in the biosynthesis of the isolated cytosporins, rather than an end product. Compound 1 contained a unique skeleton formed by the ester linkage of two moieties, cytosporin F ( 12 ) and the eudesmane-type sesquiterpene dihydroalanto glycol. Additionally, the occurrence of cyclic carbonate moieties in compounds 6 and 7 was found to be rare in nature. The antibacterial, immunosuppressive, and cytotoxic activities of all compounds derived from Eutypella sp. D-1 were evaluated. Unfortunately, only compounds 3 , 6 , 8 , and 10 – 11 displayed immunosuppressive activity, with inhibitory rates of 62.9%, 59.5%, 67.8%, 55.8%, and 68.7%, respectively, at a concentration of 5 μg/mL. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Marine Drugs 21 7 382
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic cytosporin
arctic fungus
Eutypella sp
immunosuppressive activity
Biology (General)
QH301-705.5
spellingShingle cytosporin
arctic fungus
Eutypella sp
immunosuppressive activity
Biology (General)
QH301-705.5
Hao-Bing Yu
Zhe Ning
Bo Hu
Yu-Ping Zhu
Xiao-Ling Lu
Ying He
Bing-Hua Jiao
Xiao-Yu Liu
Cytosporin Derivatives from Arctic-Derived Fungus Eutypella sp. D-1 via the OSMAC Approach
topic_facet cytosporin
arctic fungus
Eutypella sp
immunosuppressive activity
Biology (General)
QH301-705.5
description A chemical investigation of the Arctic-derived fungus Eutypella sp. D-1 based on the OSMAC (one strain many compounds) approach resulted in the isolation of five cytosporin polyketides (compounds 1 – 3 and 11 – 12 ) from rice medium and eight cytosporins (compounds 2 and 4 – 11 ) from solid defined medium. The structures of the seven new compounds, eutypelleudesmane A ( 1 ), cytosporin Y ( 2 ), cytosporin Z ( 3 ), cytosporin Y 1 ( 4 ), cytosporin Y 2 ( 5 ), cytosporin Y 3 ( 6 ), and cytosporin E 1 ( 7 ), were elucidated by analyzing their detailed spectroscopic data. Structurally, cytosporin Y 1 ( 4 ) may be a key intermediate in the biosynthesis of the isolated cytosporins, rather than an end product. Compound 1 contained a unique skeleton formed by the ester linkage of two moieties, cytosporin F ( 12 ) and the eudesmane-type sesquiterpene dihydroalanto glycol. Additionally, the occurrence of cyclic carbonate moieties in compounds 6 and 7 was found to be rare in nature. The antibacterial, immunosuppressive, and cytotoxic activities of all compounds derived from Eutypella sp. D-1 were evaluated. Unfortunately, only compounds 3 , 6 , 8 , and 10 – 11 displayed immunosuppressive activity, with inhibitory rates of 62.9%, 59.5%, 67.8%, 55.8%, and 68.7%, respectively, at a concentration of 5 μg/mL.
format Article in Journal/Newspaper
author Hao-Bing Yu
Zhe Ning
Bo Hu
Yu-Ping Zhu
Xiao-Ling Lu
Ying He
Bing-Hua Jiao
Xiao-Yu Liu
author_facet Hao-Bing Yu
Zhe Ning
Bo Hu
Yu-Ping Zhu
Xiao-Ling Lu
Ying He
Bing-Hua Jiao
Xiao-Yu Liu
author_sort Hao-Bing Yu
title Cytosporin Derivatives from Arctic-Derived Fungus Eutypella sp. D-1 via the OSMAC Approach
title_short Cytosporin Derivatives from Arctic-Derived Fungus Eutypella sp. D-1 via the OSMAC Approach
title_full Cytosporin Derivatives from Arctic-Derived Fungus Eutypella sp. D-1 via the OSMAC Approach
title_fullStr Cytosporin Derivatives from Arctic-Derived Fungus Eutypella sp. D-1 via the OSMAC Approach
title_full_unstemmed Cytosporin Derivatives from Arctic-Derived Fungus Eutypella sp. D-1 via the OSMAC Approach
title_sort cytosporin derivatives from arctic-derived fungus eutypella sp. d-1 via the osmac approach
publisher MDPI AG
publishDate 2023
url https://doi.org/10.3390/md21070382
https://doaj.org/article/91f3884534b04a2d9e2db2df8de5d4aa
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Marine Drugs, Vol 21, Iss 382, p 382 (2023)
op_relation https://www.mdpi.com/1660-3397/21/7/382
https://doaj.org/toc/1660-3397
doi:10.3390/md21070382
1660-3397
https://doaj.org/article/91f3884534b04a2d9e2db2df8de5d4aa
op_doi https://doi.org/10.3390/md21070382
container_title Marine Drugs
container_volume 21
container_issue 7
container_start_page 382
_version_ 1774714463432212480